Mouse Anti-N. meningitidis porA Recombinant Antibody (clone 151,F-9) (CAT#: FAMAB-0238JF)

Recombinant monoclonal antibody specially binds to Neisseria meningitidis PorA P1.16. This mouse-human anti-p1.7 antibody (151,F-9) can be useful to study the protective effects against meningococcal disease.


Specific Inquiry
  • Size:
  • Conjugation:
  • Endotoxin:
  • Purity:
  • Fc Engineering:
  • Published Data
  • Datasheet
  • MSDS
  • COA
FC

Figure 1 Binding of polyclonal antiGNA33 antisera and control mAbs to live encapsulated NmB strains 2996, M3735, M4207, and MC58 as determined by indirect fluorescence flow cytometry. T

Figure 1 Binding of polyclonal antiGNA33 antisera and control mAbs to live encapsulated NmB strains 2996, M3735, M4207, and MC58 as determined by indirect fluorescence flow cytometry. T

The control mAbs and antisera include an anti-serogroup B capsularspecific murine mAb (SEAM 12).

Granoff, D. M., Moe, G. R., Giuliani, M. M., Adu-Bobie, J., Santini, L., Brunelli, B., ... & Bracci, L. (2001). A novel mimetic antigen eliciting protective antibody to Neisseria meningitidis. The Journal of Immunology, 167(11), 6487-6496.

WB

Figure 2 Western blots of rGNA33 and total proteins prepared from E. coli or N. meningitidis strains using antiPorA P1.2 as the primary Ab.

Figure 2 Western blots of rGNA33 and total proteins prepared from E. coli or N. meningitidis strains using antiPorA P1.2 as the primary Ab.

The standard deviation across 5 replicates.

Granoff, D. M., Moe, G. R., Giuliani, M. M., Adu-Bobie, J., Santini, L., Brunelli, B., ... & Bracci, L. (2001). A novel mimetic antigen eliciting protective antibody to Neisseria meningitidis. The Journal of Immunology, 167(11), 6487-6496.

ELISA

Figure 3 Escape of Neisseria meningitidis strain 8047 from the PorA MAb P1.2- mediated serum bactericidal activity.

Figure 3 Escape of Neisseria meningitidis strain 8047 from the PorA MAb P1.2- mediated serum bactericidal activity.

All results are representative of at least four independent experiments.

Tauseef, I., Ali, Y. M., & Bayliss, C. D. (2013). Phase variation of PorA, a major outer membrane protein, mediates escape of bactericidal antibodies by Neisseria meningitidis. Infection and immunity, 81(4), 1374-1380.

IHC

Figure 4 Immunohistochemical staining of inflammatory cells and the vascular endothelium in skin biopsy samples from patients with meningococcal disease.

Figure 4 Immunohistochemical staining of inflammatory cells and the vascular endothelium in skin biopsy samples from patients with meningococcal disease.

Arrows indicate positive immunoperoxidase staining (brown) with the appropriate specific mouse monoclonal antibody (nuclei were counterstained with hematoxylin).

Harrison, O. B., Robertson, B. D., Faust, S. N., Jepson, M. A., Goldin, R. D., Levin, M., & Heyderman, R. S. (2002). Analysis of pathogen-host cell interactions in purpura fulminans: expression of capsule, type IV pili, and PorA by Neisseria meningitidis in vivo. Infection and immunity, 70(9), 5193-5201.


Specifications

  • Immunogen
  • Deoxycholate-extracted OMVs from strain 44/76
  • Host Species
  • Mouse
  • Type
  • Mouse IgG
  • Specificity
  • Neisseria meningitidis PorA P1.16
  • Species Reactivity
  • N. meningitidis
  • Clone
  • 151,F-9
  • Applications
  • WB, ELISA, IHC, FC
  • Related Disease
  • Meningitis

Product Property

  • Purity
  • >95% as determined by SDS-PAGE and HPLC analysis
  • Concentration
  • Please refer to the vial label for the specific concentration.
  • Buffer
  • PBS
  • Preservative
  • No preservatives
  • Storage
  • Centrifuge briefly prior to opening vial. Store at +4°C short term (1-2 weeks). Aliquot and store at -20°C long term. Avoid repeated freeze/thaw cycles.

Applications

  • Application Notes
  • The N. meningitidis porA antibody has been reported in applications of Western Blot, Enzyme-linked Immunosorbent Assay, Immunohistochemistry, Flow Cytometry.

Target

  • Alternative Names
  • Outer membrane protein PorA; PorA

Product Notes

This is a product of Creative Biolabs' Hi-Affi™ recombinant antibody portfolio, which has several benefits including:

• Increased sensitivity
• Confirmed specificity
• High repeatability
• Excellent batch-to-batch consistency
• Sustainable supply
• Animal-free production

See more details about Hi-Affi™ recombinant antibody benefits.

Downloads

Download resources about recombinant antibody development and antibody engineering to boost your research.

See other products for "Clone 151,F-9"

See other products for "N. meningitidis porA"

Customer Reviews and Q&As

Submit a review or a question
There are currently no Customer reviews or questions for FAMAB-0238JF. Click the button above to contact us or submit your feedback about this product.
View the frequently asked questions answered by Creative Biolabs Support.

For Research Use Only. Not For Clinical Use.

For research use only. Not intended for any clinical use. No products from Creative Biolabs may be resold, modified for resale or used to manufacture commercial products without prior written approval from Creative Biolabs.

Send Inquiry

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

© 2024 Creative Biolabs.
  • 0
  • 0
Cart

    Go to compare